Dr. John Koreth, MD

Claim this profile

Dana Farber Cancer Institute

Studies Myelodysplastic syndrome
Studies T-Lymphoblastic Leukemia/Lymphoma
2 reported clinical trials
8 drugs studied

Area of expertise

1Myelodysplastic Syndrome
John Koreth, MD has run 2 trials for Myelodysplastic syndrome. Some of their research focus areas include:
HLA-A positive
HLA-A negative
HLA positive
2T-Lymphoblastic Leukemia/Lymphoma
John Koreth, MD has run 2 trials for T-Lymphoblastic Leukemia/Lymphoma. Some of their research focus areas include:
HLA-A positive
HLA-A negative
HLA positive

Affiliated Hospitals

Image of trial facility.
Dana Farber Cancer Institute
Image of trial facility.
Brigham And Women's Hospital

Clinical Trials John Koreth, MD is currently running

More about John Koreth, MD

Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments John Koreth, MD has experience with
  • CD25hi Treg Depleted DLI
  • Ipilimumab
  • Cyclophosphamide
  • Fludarabine
  • Radiation
  • Thiotepa

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John Koreth, MD specialize in?
John Koreth, MD focuses on Myelodysplastic syndrome and T-Lymphoblastic Leukemia/Lymphoma. In particular, much of their work with Myelodysplastic syndrome has involved HLA-A positive patients, or patients who are HLA-A negative.
Is John Koreth, MD currently recruiting for clinical trials?
Yes, John Koreth, MD is currently recruiting for 1 clinical trial in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that John Koreth, MD has studied deeply?
Yes, John Koreth, MD has studied treatments such as CD25hi Treg depleted DLI, Ipilimumab, Cyclophosphamide.
What is the best way to schedule an appointment with John Koreth, MD?
Apply for one of the trials that John Koreth, MD is conducting.
What is the office address of John Koreth, MD?
The office of John Koreth, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02115 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.